Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02751931
Brief Title: Open-label Phase 3 Study With Mirabegron in Children From 3 to Less Than 18 Years of Age With Neurogenic Detrusor Overactivity (Crocodile)

First Submitted : April 22, 2016
First Submitted that Met QC Criteria : April 22, 2016
First Posted : April 26, 2016 (Estimate)

Results First Submitted : April 29, 2020
Results First Submitted that Met QC Criteria : April 29, 2020
Results First Posted : May 12, 2020

Certification/Extension First Submitted : October 31, 2019
Certification/Extension First Submitted that Met QC Criteria : October 31, 2019
Certification/Extension First Posted : November 6, 2019

Last Update Submitted that Met QC Criteria : June 24, 2021
Last Update Posted : June 28, 2021